Very little is known about the incidence, onset, time course, and symptomatology of premature menopause induced by breast cancer therapy. No prospective study exists. The purpose of the present study is to identify determinants of treatment-related amenorrhea nad its effect on quality of life in a cohort of youg breast cancer patients.
Study Type
OBSERVATIONAL
Enrollment
810
Data collection instruments will be obtained at baseline and every six months. Follow-up will range between 26-42 months for participants.
Memorial Sloan Kettering Cancer Center
New York, New York, United States
The overall goal of the proposed research is to recruit and follow young breast cancer patients aged 45 and younger, in order to examine menstrual cycle maintenance.
Time frame: Conclusion of the study
Examine possible predictors of treatment-related amenorrhea including age, smoking history, race, and treatment variables
Time frame: Conclusion of study
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.